Table 3.
Posttreatment score | Effect size | Post | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MEASURE/Prescore | Completer | ITT | pre vs post (Cohen's d) | treatment vs. control (Cohen's d corrected) | Recovery rate | Improvement rate | |||||||||||
Treatment or WL | N (N completer) | Drop-out | M | SD | M | SD | M | SD | Completer | ITT | Completer | ITT | Completer | ITT | Completer | ITT | |
Zlotnick et al., 1997 (A) |
AM TAU+WL |
24 (16) 24 (17) |
33% 29% |
DTS
66.9 74.7 |
22.00 25.83 |
45.76 73.06 |
34.12 29.86 |
52.2a 73.5 |
0.91 0.07 |
0.63a 0.05 |
0.84 |
0.58a |
87% 41% |
61%a 30% |
– |
– |
|
Classen et al., 2001 (B) |
TFT+PFT WL only |
14+7 34 |
NR |
TSC-40
g
– – |
– – |
– – |
– – |
– – |
– – |
8.1 3.8 |
17.0 14.1 |
– – |
– – |
– – |
– – |
– – |
– – |
Cloitre et al., 2002 (B) |
STAIR+PE WL only STAIR+PE WL only |
31 (22) 27 (24) |
29% 11% |
MPSS-SR
69 73 CAPS 69 69 |
16.6 18.6 16.3 16.6 |
29 58 31 62 |
27.6 28.6 25.2 22.7 |
40.6a 59.7 42.0 62.7 |
2.31 0.87 2.36 0.43 |
1.64a 0.77 1.68 0.39 |
1.45 1.93 |
0.87a 1.29 |
77% 25% |
55%a 22% |
46% 4% |
33%a 4% |
|
Chard, 2005 (B) |
CPT-SA WL (MA) CPT-SA WL (MA) |
36 (30) 35 (28) |
17% 20% |
CAPS
65.5 68.3 MPSS-SR 57.6 57.5 |
26.4 23.7 22.9 24.7 |
9.00 63.0 7.54 57.7 |
11.0 30.7 9.51 27.5 |
18.4a 64.0 15.9 57.7 |
2.29 0.22 2.14 −0.01 |
1.91a 0.17 1.78 −0.01 |
2.07 2.15 |
1.73a 1.79 |
93% 26% |
78%a 21% |
79% 4% |
66%a 3% |
|
McDonagh et al., 2005 (A) |
CBT PCT WL only |
29 (17) 22 (20) 23 (20) |
41% 9% 13% |
CAPS
67.1 67.5 70.0 |
18.4 15.1 16.9 |
38.5 44.9 62.5 |
27.7 22.1 17.0 |
53.1 47.2 65.5 |
28.8 22.4 18.6 |
1.75 1.39 0.44 |
1.03 1.26 0.40 |
1.29 0.93 0.37c |
0.63 0.86 −0.23c |
47% 35% 20% |
28% 32% 17% |
– |
– |
Cloitre et al., 2010 (A) |
STAIR/PE STAIR/Sup Sup/PE STAIR/PE STAIR/Sup Sup/PE |
33 (28) 38 (28) 33 (20) |
15% 26% 39% |
CAPS
63.1 64.3 64.5 PTSD-SR 36.7 39.9 38.2 |
18.3 21.2 15.9 12.9 12.7 11.1 |
27.3b 20.9 23.6 9.95 5.43 6.52 |
|
32.7 32.3 39.7 14.0 14.5 19.0 |
19.4 23.0 18.3 11.5 12.8 9.83 |
1.94b 2.35 2.22 2.21 2.85 2.84 |
1.65 1.73 1.34 1.87 2.10 1.59 |
−0.28d 0.14e −0.41f −0.64d 0.23e −0.41f |
0.30d 0.39e −0.09f −0.22d 0.51e 0.29f |
72%b 64% 55% |
61% 47% 33% |
32%b 33% 10% |
27% 24% 6% |
Dorrepaal et al., 2012 (A) |
CBT group TAU+WL |
38 (31) 33 (29) |
18% 12% |
DTS crsf 91.4 80.5 |
21.8 23.1 |
66.7 65.5 |
29.4 30.3 |
69.6 66.5 |
27.4 29.8 |
1.12 0.68 |
0.99 0.63 |
0.44 |
0.35 |
– |
– |
55% 24% |
45% 21% |
AM=affect management; CAPS=Clinician-Administered PTSD Scale; CBT=cognitive behavioral therapy; CPT-SA=cognitive processing therapy for sexual abuse survivors; DTS=Davidson Trauma Scale; ITT=intention-to-treat; M=mean; MA=minimal attention; MPSS-SR=Modified Posttraumatic Stress Disorder Symptom Scale—Self-Report; NR=not reported; PTSD-SR=PTSD Self-Report; PE=prolonged exposure; PFT=present focused therapy; SD=standard deviation; STAIR= Skills Training in Affect and Interpersonal Regulation; TAU=treatment as usual; TSC-40=Trauma Symptom Checklist-40; TFT=trauma focused therapy; WL=waiting list.
Mean ITT is estimated from mean completers, N ITT and N completers, assuming non-completers did not change;
mean completers is estimated from mean ITT, N completers and N ITT, assuming non-completers did not change;
CBT vs. PCT;
STAIR/PE vs. Sup/PE;
STAIR/Sup vs. Sup/PE;
STAIR/PE vs. STAIR/Sup;
change scores as reported in article, unknown if standardized.